Ophthalmology Times Europe Newsletter

To view this email as a web page, click here.

Determining DR progression: Much work still needs to be done

Primary modeling studies that are well structured and easy to use are needed for clinicians to reliably predict progression of diabetic retinopathy, need for treatment, and visual loss.

Sustained-release implant promising for long-term IOP reduction

Dr E. Randy Craven discusses sustained-release implants for long-term IOP reduction.

Nerve growth factor promising for dry eye

Recombinant human nerve growth factor (rhNGF) has shown promise as a treatment for dry eye disease in a phase I clinical trial.

Children with behavioural problems run a risk from laser pointers

Considering BID ocular steroid post-cataract surgery

Primary posterior optic capture offers many advantages in cataract surgery

OPS at 50: How imaging led to birth of new profession

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.